178 related articles for article (PubMed ID: 16595769)
1. The retinoic acid paradox in cancer chemoprevention.
Freemantle SJ; Dragnev KH; Dmitrovsky E
J Natl Cancer Inst; 2006 Apr; 98(7):426-7. PubMed ID: 16595769
[No Abstract] [Full Text] [Related]
2. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
3. An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
Kim ES; Hong WK
J Natl Cancer Inst; 2005 Apr; 97(7):468-70. PubMed ID: 15812064
[No Abstract] [Full Text] [Related]
4. Chemoprevention of squamous cell carcinoma of the head and neck.
Wrangle JM; Khuri FR
Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
[TBL] [Abstract][Full Text] [Related]
5. Retinoids in chemoprevention of head and neck carcinogenesis.
Lippman SM; Benner SE; Hong WK
Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention strategies for lung and upper aerodigestive tract cancer.
Benner SE; Lippman SM; Hong WK
Cancer Res; 1992 May; 52(9 Suppl):2758s-2763s. PubMed ID: 1563008
[TBL] [Abstract][Full Text] [Related]
7. Molecularly targeted approaches to the chemoprevention of lung cancer.
Khuri FR; Cohen V
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968
[TBL] [Abstract][Full Text] [Related]
8. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.
Jones E; Korzenko A; Kriegel D
J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of head and neck cancer.
Voravud N
J Med Assoc Thai; 1996 Mar; 79(3):185-93. PubMed ID: 8708501
[TBL] [Abstract][Full Text] [Related]
10. Current status of chemoprevention of head and neck cancer.
Benner SE; Lippman SM; Hong WK
Oncology (Williston Park); 1992 Aug; 6(8):61-6; discussion 66-8, 71 passim. PubMed ID: 1386997
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of oral squamous cell carcinomas.
Scheer M; Kuebler AC; Zöller JE
Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a placebo run-in period in a head and neck cancer chemoprevention trial.
Hudmon KS; Chamberlain RM; Frankowski RF
Control Clin Trials; 1997 Jun; 18(3):228-40. PubMed ID: 9204223
[TBL] [Abstract][Full Text] [Related]
13. Head and neck cancer chemoprevention gets a shot in the arm.
Khuri FR; Shin DM
J Clin Oncol; 2008 Jan; 26(3):345-7. PubMed ID: 18202405
[No Abstract] [Full Text] [Related]
14. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
15. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
16. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
Haffty BG
Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
[No Abstract] [Full Text] [Related]
17. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
18. Higher potency of the synthetic retinoid MX3350-1 compared to the natural all-trans-retinoic acid in modulation of cell cycle and induction of apoptosis in head and neck squamous carcinoma cells.
Chun KH; Lotan R
Cell Death Differ; 2006 Oct; 13(10):1830-2. PubMed ID: 16601752
[No Abstract] [Full Text] [Related]
19. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
Bhatia AK; Lee JW; Pinto HA; Jacobs CD; Limburg PJ; Rubin P; Arusell RM; Dunphy EP; Khandekar JD; Reiner SA; Baez-Diaz L; Celano P; Li S; Li Y; Burtness BA; Adams GL; Pandya KJ
Cancer; 2017 Dec; 123(23):4653-4662. PubMed ID: 28786105
[TBL] [Abstract][Full Text] [Related]
20. Synthetic retinoids: recent developments concerning structure and clinical utility.
Kagechika H; Shudo K
J Med Chem; 2005 Sep; 48(19):5875-83. PubMed ID: 16161990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
